The evidence-backed peptide lexicon
Explore peptides through claims that stay connected to the research behind them.
Building the most complete, traceable peptide knowledge base on the internet.
Evidence example
In STEP 1, adults without diabetes received semaglutide or placebo alongside lifestyle intervention for 68 weeks; mean weight change favored semaglutide.
semaglutide-weight-step-1The result applies to the studied formulation, dose, population, duration, and accompanying lifestyle intervention.
Built claim by claim.
Every material claim stays attached to the source, population, endpoint, and date behind it.
Study design, independence, and relevance matter more than a raw citation count.
New research can strengthen, qualify, or contradict what the lexicon currently says.
Peptide directory · Edition 01
Semaglutide is the first immutable Evidence Ledger profile. The remaining library is being migrated claim by claim rather than presented as equally complete.
One evidence record · Three reading modes
The explanation changes with you. The evidence underneath it does not.
A clear orientation to what a peptide is, what it has been studied for, and the limits that matter.
Follow mechanisms, anatomy, products, and definitions without losing the evidence trail.
Open study design, population, outcomes, limitations, and the exact source for every claim.
The trust model
Peplexicon separates ingredient from product, mechanism from outcome, and source-backed evidence from the unfiltered research universe.
Sources remain visible. Limitations stay attached. When the research changes, the record can change with it.
Explore the semaglutide pilot